New Ovarian Cancer Drug Offers More Time and Better Quality of Life
A new drug has become available that demonstrates improved survival rates for patients in this group. Furthermore, the treatment is well-tolerated, and patients report finding it easier to manage compared to standard chemotherapy. This marks a significant advancement in care for these individuals.
John Q. Hosedrinker